Combination Nicotine Replacement Therapy (NRT) Regimen
The recommended regimen for combination NRT consists of a 21 mg nicotine patch plus a short-acting NRT form (lozenge, gum, inhaler, or nasal spray) for breakthrough cravings, administered for a minimum of 12 weeks with possible extension to 6-12 months for continued cessation support. 1
Standard Dosing Protocol
Initial Phase (First 12 Weeks)
Long-acting component:
- Apply one 21 mg nicotine patch daily to clean, dry, non-hairy skin on the upper body or outer arm
- Apply in the morning and wear for 24 hours
- Rotate application sites daily to prevent skin irritation
- If 21 mg patch is not effective (continued significant cravings), consider increasing to 35 or 42 mg patch 1, 2
Short-acting component (for breakthrough cravings):
- Use one of the following as needed:
- Nicotine gum (2-4 mg)
- Nicotine lozenge (2-4 mg)
- Nicotine inhaler
- Nicotine nasal spray
- Use one of the following as needed:
Titration and Duration
For Heavy Smokers (>10 cigarettes/day)
- Weeks 1-4: 21 mg patch daily + short-acting NRT as needed
- Weeks 5-6: Step down to 14 mg patch daily + short-acting NRT as needed
- Weeks 7-8: Step down to 7 mg patch daily + short-acting NRT as needed 2
For Light Smokers (≤10 cigarettes/day)
- Weeks 1-6: 14 mg patch daily + short-acting NRT as needed
- Weeks 7-8: Step down to 7 mg patch daily + short-acting NRT as needed 2
Extended Treatment
- Treatment may be extended beyond the initial 12 weeks (up to 6-12 months) to promote continued cessation in challenging cases 1, 2
- Continue the short-acting NRT component for longer periods if needed to manage breakthrough cravings
Follow-up Schedule
- Initial follow-up within 2-3 weeks after starting therapy
- Additional follow-up at 12-week intervals during therapy
- Final assessment at the end of therapy 1
Efficacy and Benefits
- Combination NRT has shown significantly higher abstinence rates (36.5%) at 6 months compared to patch alone (23.4%) 2, 3
- The dual approach provides both steady background nicotine levels (patch) and immediate relief for breakthrough cravings (short-acting NRT) 4
Common Side Effects and Management
- Patch-related: Skin irritation at application site (rotate sites daily)
- Short-acting NRT-related: Throat irritation, mouth soreness, hiccups, nausea
- General: Sleep disturbances, headache, dizziness
- Blood nicotine levels from combination NRT remain significantly lower than from smoking cigarettes 1
Important Considerations
- Nicotine withdrawal symptoms typically peak within 1-2 weeks of quitting and then subside
- If reduction efforts stall or reaching total abstinence seems unlikely, consider adjusting the dose or switching to a different pharmacotherapy 1
- Combining NRT with behavioral therapy significantly improves success rates 1, 2
- Patients should not smoke while using nicotine patches as this may exacerbate symptoms 2
Relapse Management
- For patients who relapse, consider:
- Continuing/resuming combination NRT with additional behavioral therapy
- Increasing patch dose if cravings are not adequately controlled
- Switching to varenicline if combination NRT is ineffective 1
Combination NRT represents one of the most effective pharmacological approaches to smoking cessation, with high-certainty evidence supporting its superiority over single-form NRT 3. The regimen outlined above balances efficacy with practicality and addresses the need for both steady background nicotine levels and on-demand relief for breakthrough cravings.